- Home
- THAR vs XWEL Comparison
THAR vs XWEL Comparison
Compare THAR & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- XWEL
- Stock Information
- Founded
- THAR 2017
- XWEL 2006
- Country
- THAR United States
- XWEL United States
- Employees
- THAR N/A
- XWEL N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- XWEL Other Consumer Services
- Sector
- THAR Health Care
- XWEL Consumer Discretionary
- Exchange
- THAR Nasdaq
- XWEL Nasdaq
- Market Cap
- THAR 5.5M
- XWEL 4.7M
- IPO Year
- THAR 2022
- XWEL N/A
- Fundamental
- Price
- THAR $1.46
- XWEL $1.11
- Analyst Decision
- THAR Strong Buy
- XWEL
- Analyst Count
- THAR 1
- XWEL 0
- Target Price
- THAR $17.00
- XWEL N/A
- AVG Volume (30 Days)
- THAR 43.3K
- XWEL 30.1K
- Earning Date
- THAR 08-08-2025
- XWEL 08-13-2025
- Dividend Yield
- THAR N/A
- XWEL N/A
- EPS Growth
- THAR N/A
- XWEL N/A
- EPS
- THAR N/A
- XWEL N/A
- Revenue
- THAR N/A
- XWEL $32,194,000.00
- Revenue This Year
- THAR N/A
- XWEL N/A
- Revenue Next Year
- THAR N/A
- XWEL N/A
- P/E Ratio
- THAR N/A
- XWEL N/A
- Revenue Growth
- THAR N/A
- XWEL 1.33
- 52 Week Low
- THAR $0.95
- XWEL $0.70
- 52 Week High
- THAR $6.39
- XWEL $2.41
- Technical
- Relative Strength Index (RSI)
- THAR 39.40
- XWEL 55.26
- Support Level
- THAR $1.60
- XWEL $0.90
- Resistance Level
- THAR $1.75
- XWEL $1.42
- Average True Range (ATR)
- THAR 0.10
- XWEL 0.09
- MACD
- THAR -0.04
- XWEL 0.01
- Stochastic Oscillator
- THAR 1.01
- XWEL 38.00
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About XWEL XWELL Inc.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.